BioPharma APAC

Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland

Company to invest in two major Life Science projects over five years Significantly increases membrane manufacturing capacities and enables construction ...

May 23, 2022 | News

Pharmapack Europe Awards Winners 2022

Pharmapack Europe (#PharmapackEU) announces the winners of the 2022 Pharmapack Awards spanning five categories in the Exhibitor Innovation Award...

May 19, 2022 | News

Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement...

May 03, 2022 | News

AGC to Expand Synthetic Pharmaceutical Production Base in Spain

A new building with a total floor area of 7,500 m2 will be constructed on the company's site, increasing the current production capacity by 30%. ...

April 11, 2022 | News

Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the EU to Adolescents (Ages 12-17)

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

April 01, 2022 | News

Thermo Fisher Scientific Announces New Norwegian-Based Sales and Services Team

Scientists in Norway will now benefit from a locally-based team that will provide a single point of contact for access to Thermo Fisher Scientific’s ...

March 31, 2022 | News

Expansion of Biologics CDMO & Manufacturing Capacity Offerings at Paras Biopharmaceuticals Finland

Due to the company’s technologies, its deep scientific knowhow and the specialized skills of the Paras Biopharma team, all of Paras Biopharmaceutical...

March 29, 2022 | News

Rentschler Biopharma and Vetter Unveil Xpert Alliance

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that t...

March 29, 2022 | News

Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®

Under the terms of the agreement, Xiel, a specialist distributor of Nuclear Medicine, Radiotherapy and Diagnostic Radiology technologies across the U.K. an...

March 29, 2022 | News

Singleron Acquires Proteona

Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their...

March 08, 2022 | News

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...

March 08, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

March 03, 2022 | News

Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...

February 18, 2022 | News

Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries

Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted marketing authorization applications for ritonavir (100 mg film-coated tablet) in&n...

February 14, 2022 | News

Stay Connected